Navigation Links
Macrogen Corp. Announces the Inception of Macrogen Clinical Laboratory (MCL)
Date:2/28/2013

Rockville, MD (PRWEB) February 28, 2013

Macrogen Corporation, which provides quality DNA Sequencing services to the biotechnology and research community, announced the inception of Macrogen Clinical Laboratory (MCL) in Rockville, Maryland.

Supported by Macrogen’s excellent infrastructure and extensive experiences in NGS services, Macrogen Clinical Laboratory (MCL) is expected to receive a CLIA (Clinical Laboratory Improvement Amendments) certification to offer clinical diagnostic sequencing within the coming months.

“The inception of MCL signifies our confidence in the future of healthcare market and our adaptability to the rapidly growing demand for clinical next-generation sequencing service,” Mr. Kyung Joon Shin of Macrogen Corp. commented. “With MCL in place, we look forward to deliver specialized service in the personalized medicine area.”

About Macrogen Corporation
Macrogen Corp., a member of Macrogen Group with facilities in Asia, Europe, and the United States, is an international provider of DNA sequencing services. Macrogen Corp. provides the absolute best quality results at the fastest possible turnaround time. For additional information, please visit our website at http://www.macrogenusa.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10474767.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
2. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
3. Plastics Color Corp. Announces Custom-Blended Antimicrobials for Polymers
4. Tonicology LLC Partners with Taiwan's CGB, Corp. to Offer Pure Extracts of Rare Herbal Supplements
5. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
6. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
7. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
8. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
9. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
10. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
11. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... HOLLOWAY AMERICA, a leading custom ... Rocky Mountain Chapter 21st Annual Vendor Exhibition on Thursday, February 18, 2016. The ... for its annual event, which will run from 3:00 p.m. - 8:30 p.m. ...
(Date:2/10/2016)... ... February 10, 2016 , ... SonaCare ... training and support program, Sonalink™ remote monitoring. The inaugural launch of this new ... February 5th, connecting Dr. Samuel Peretsman to a HIFU technical expert at SonaCare ...
(Date:2/10/2016)... ... February 10, 2016 , ... Curoverse announced today that ... Arvados provides capabilities for managing and processing genomic and health data at petabyte ... institutions collecting and analyzing genomic data,” said Adam Berrey chief executive officer at ...
(Date:2/10/2016)... Jolla CA (PRWEB) , ... February 10, 2016 , ... ... new agents for the treatment of Alzheimer’s disease, announced today it has been selected ... February 18th at the Breakers in Palm Beach, Florida. The purpose of the ...
Breaking Biology Technology:
(Date:2/3/2016)... Feb. 3, 2016 ... of the "Emotion Detection and Recognition ... and Others), Software Tools (Facial Expression, Voice ... Users,and Regions - Global forecast to 2020" ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
Breaking Biology News(10 mins):